Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study
Publication
, Conference
Szabolcs, P; Visani, G; Locatelli, F; Kleiner, G; Talano, J; Nemecek, E; Kurtzberg, J
Published in: Biology of Blood and Marrow Transplantation
February 2010
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2010
Volume
16
Issue
2
Start / End Page
S298 / S298
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Szabolcs, P., Visani, G., Locatelli, F., Kleiner, G., Talano, J., Nemecek, E., & Kurtzberg, J. (2010). Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study. In Biology of Blood and Marrow Transplantation (Vol. 16, pp. S298–S298). Elsevier BV. https://doi.org/10.1016/j.bbmt.2009.12.426
Szabolcs, P., G. Visani, F. Locatelli, G. Kleiner, J. Talano, E. Nemecek, and J. Kurtzberg. “Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study.” In Biology of Blood and Marrow Transplantation, 16:S298–S298. Elsevier BV, 2010. https://doi.org/10.1016/j.bbmt.2009.12.426.
Szabolcs P, Visani G, Locatelli F, Kleiner G, Talano J, Nemecek E, et al. Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2010. p. S298–S298.
Szabolcs, P., et al. “Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study.” Biology of Blood and Marrow Transplantation, vol. 16, no. 2, Elsevier BV, 2010, pp. S298–S298. Crossref, doi:10.1016/j.bbmt.2009.12.426.
Szabolcs P, Visani G, Locatelli F, Kleiner G, Talano J, Nemecek E, Kurtzberg J. Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study. Biology of Blood and Marrow Transplantation. Elsevier BV; 2010. p. S298–S298.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2010
Volume
16
Issue
2
Start / End Page
S298 / S298
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences